Skip to main content
ArticleOPEN ACCESS

Potential of heparin and nafamostat combination therapy for COVID-19

Journal of Thrombosis and Haemostasis
DOI: 10.1111/jth.14858
77Citations
Citations of this article
193Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Asakura, H., & Ogawa, H. (2020, June 1). Potential of heparin and nafamostat combination therapy for COVID-19. Journal of Thrombosis and Haemostasis. Blackwell Publishing Ltd. https://doi.org/10.1111/jth.14858

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free